Yunnan Baiyao Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000008X7
CNY
55.73
0.35 (0.63%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.66 M

Shareholding (Jun 2017)

FII

0.01%

Held by 1 FIIs

DII

99.99%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

The company declared positive results in Mar'25 after negative results in Dec'24

  • OPERATING CASH FLOW(Y) Highest at CNY 4,888.72 MM
  • INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
  • RAW MATERIAL COST(Y) Fallen by -7.16% (YoY)
2

With ROE of 12.59%, it has a attractive valuation with a 2.42 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 97,589 Million (Large Cap)

stock-summary
P/E

19.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

4.43%

stock-summary
Debt Equity

-0.33

stock-summary
Return on Equity

12.59%

stock-summary
Price to Book

2.42

Revenue and Profits:
Net Sales:
10,343 Million
(Quarterly Results - Jun 2025)
Net Profit:
1,717 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.23%
0%
-6.23%
6 Months
-2.6%
0%
-2.6%
1 Year
-3.04%
0%
-3.04%
2 Years
10.69%
0%
10.69%
3 Years
-1.94%
0%
-1.94%
4 Years
-12.29%
0%
-12.29%
5 Years
-20.84%
0%
-20.84%

Yunnan Baiyao Group Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
5.45%
EBIT Growth (5y)
4.90%
EBIT to Interest (avg)
49.51
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
0.91
Tax Ratio
19.42%
Dividend Payout Ratio
44.52%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
15.36%
ROE (avg)
10.59%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
2.42
EV to EBIT
17.62
EV to EBITDA
16.36
EV to Capital Employed
3.11
EV to Sales
2.08
PEG Ratio
1.27
Dividend Yield
4.43%
ROCE (Latest)
17.64%
ROE (Latest)
12.59%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2017stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -4.12% vs 7.42% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -10.92% vs 340.67% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,343.50",
          "val2": "10,787.90",
          "chgp": "-4.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,389.50",
          "val2": "2,066.20",
          "chgp": "-32.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.60",
          "val2": "6.20",
          "chgp": "-25.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "29.10",
          "val2": "41.00",
          "chgp": "-29.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,717.10",
          "val2": "1,927.50",
          "chgp": "-10.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "124.80%",
          "val2": "182.40%",
          "chgp": "-5.76%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.29% vs 7.23% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 15.63% vs 45.14% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "39,790.20",
          "val2": "38,900.50",
          "chgp": "2.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,923.30",
          "val2": "3,994.50",
          "chgp": "23.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "73.90",
          "val2": "58.60",
          "chgp": "26.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "103.30",
          "val2": "66.20",
          "chgp": "56.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,767.10",
          "val2": "4,122.60",
          "chgp": "15.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "114.90%",
          "val2": "93.10%",
          "chgp": "2.18%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
10,343.50
10,787.90
-4.12%
Operating Profit (PBDIT) excl Other Income
1,389.50
2,066.20
-32.75%
Interest
4.60
6.20
-25.81%
Exceptional Items
29.10
41.00
-29.02%
Consolidate Net Profit
1,717.10
1,927.50
-10.92%
Operating Profit Margin (Excl OI)
124.80%
182.40%
-5.76%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -4.12% vs 7.42% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -10.92% vs 340.67% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
39,790.20
38,900.50
2.29%
Operating Profit (PBDIT) excl Other Income
4,923.30
3,994.50
23.25%
Interest
73.90
58.60
26.11%
Exceptional Items
103.30
66.20
56.04%
Consolidate Net Profit
4,767.10
4,122.60
15.63%
Operating Profit Margin (Excl OI)
114.90%
93.10%
2.18%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 2.29% vs 7.23% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 15.63% vs 45.14% in Dec 2023

stock-summaryCompany CV
About Yunnan Baiyao Group Co., Ltd. stock-summary
stock-summary
Yunnan Baiyao Group Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available